Table 2.

Efficacy summary

IWG-MRT-ECNM response*, n (%)Overall population (N = 10)
ORR (CR + PR +CI)0 (0)
Stable disease8 (80)
Progressive disease1 (10)
Not evaluable1 (10)
  • For the full listing and definitions of response criteria, please see the IWG-MRT-ECNM consensus guidelines.29

  • CI, clinical improvement